Department of Dermatology, Peking University First Hospital, Beijing, China.
Yemiwon Aesthetic Clinic, Seoul, South Korea.
J Cosmet Dermatol. 2022 Sep;21(9):3779-3786. doi: 10.1111/jocd.15156. Epub 2022 Jun 25.
The use of hyaluronic acid (HA) fillers for medical aesthetic purposes is increasing worldwide. Nonetheless, adverse events do occur because of patient-specific issues, injection technique, or product factors. It would be mandatory to consider cultural and anatomical features of Asians in preventing and managing the complications of HA injections.
Literature search of studies looking at current evidence and guidelines on the management of complications following HA filler injections in Asian patients was conducted. This was followed by an expert group discussion that was convened to reach consensus recommendations on the best clinical practices.
The expert panel provided specific recommendations focusing on the safe use of soft tissue fillers in Asian patients, including early identification of adverse events and how to prevent and comprehensively manage these outcomes.
Here, we provide consensus statements of Asian experts in dermatology, plastic surgery, ophthalmology, and aesthetic medicine mainly focusing on AEs with higher risk for Asians and can be used to guide physicians in treating Asian population.
全球范围内,出于医学美容目的而使用透明质酸(HA)填充剂的情况日益增多。然而,由于患者个体问题、注射技术或产品因素,不良事件确实会发生。在预防和处理 HA 注射并发症时,考虑亚洲人的文化和解剖学特征是强制性的。
对研究 HA 填充剂注射后亚洲患者并发症管理的当前证据和指南进行文献检索。随后,召集专家组进行讨论,就最佳临床实践达成共识建议。
专家组提出了具体建议,重点关注亚洲患者软组织填充剂的安全使用,包括早期识别不良反应以及如何预防和全面管理这些后果。
在这里,我们提供了皮肤科、整形外科学、眼科和美容医学方面的亚洲专家的共识声明,主要侧重于亚洲人风险更高的不良反应,可用于指导医生治疗亚洲人群。